377 related articles for article (PubMed ID: 24194477)
1. Nomogram for predicting the benefit of neoadjuvant chemoradiotherapy for patients with esophageal cancer: a SEER-Medicare analysis.
Eil R; Diggs BS; Wang SJ; Dolan JP; Hunter JG; Thomas CR
Cancer; 2014 Feb; 120(4):492-8. PubMed ID: 24194477
[TBL] [Abstract][Full Text] [Related]
2. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
[TBL] [Abstract][Full Text] [Related]
3. Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study.
Schwer AL; Ballonoff A; McCammon R; Rusthoven K; D'Agostino RB; Schefter TE
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):449-55. PubMed ID: 18538500
[TBL] [Abstract][Full Text] [Related]
4. Chemoradiotherapy before and after surgery for locally advanced esophageal cancer: a SEER-Medicare analysis.
Hong JC; Murphy JD; Wang SJ; Koong AC; Chang DT
Ann Surg Oncol; 2013 Nov; 20(12):3999-4007. PubMed ID: 23800897
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis.
Nabeya Y; Ochiai T; Matsubara H; Okazumi S; Shiratori T; Shuto K; Aoki T; Miyazaki S; Gunji Y; Uno T; Ito H; Shimada H
Dis Esophagus; 2005; 18(6):388-97. PubMed ID: 16336610
[TBL] [Abstract][Full Text] [Related]
6. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.
Shridhar R; Hoffe SE; Almhanna K; Weber JM; Chuong MD; Karl RC; Meredith K
Ann Surg Oncol; 2013 Sep; 20(9):3038-43. PubMed ID: 23625142
[TBL] [Abstract][Full Text] [Related]
7. Predictors of survival in patients with persistent nodal metastases after preoperative chemotherapy for esophageal cancer.
Stiles BM; Christos P; Port JL; Lee PC; Paul S; Saunders J; Altorki NK
J Thorac Cardiovasc Surg; 2010 Feb; 139(2):387-94. PubMed ID: 20006355
[TBL] [Abstract][Full Text] [Related]
8. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.
Peyre CG; Hagen JA; DeMeester SR; Altorki NK; Ancona E; Griffin SM; Hölscher A; Lerut T; Law S; Rice TW; Ruol A; van Lanschot JJ; Wong J; DeMeester TR
Ann Surg; 2008 Oct; 248(4):549-56. PubMed ID: 18936567
[TBL] [Abstract][Full Text] [Related]
9. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma.
Rizk NP; Venkatraman E; Bains MS; Park B; Flores R; Tang L; Ilson DH; Minsky BD; Rusch VW;
J Clin Oncol; 2007 Feb; 25(5):507-12. PubMed ID: 17290058
[TBL] [Abstract][Full Text] [Related]
10. A clinical nomogram predicting pathologic lymph node involvement in esophageal cancer patients.
Gaur P; Sepesi B; Hofstetter WL; Correa AM; Bhutani MS; Vaporciyan AA; Watson TJ; Swisher SG;
Ann Surg; 2010 Oct; 252(4):611-7. PubMed ID: 20881767
[TBL] [Abstract][Full Text] [Related]
11. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
12. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
[TBL] [Abstract][Full Text] [Related]
13. Lymph node identification following neoadjuvant therapy in rectal cancer: A stage-stratified analysis using the surveillance, epidemiology, and end results (SEER)-medicare database.
Ecker BL; Paulson EC; Datta J; Jeganathan AN; Aarons C; Kelz RR; Mahmoud NN
J Surg Oncol; 2015 Sep; 112(4):415-20. PubMed ID: 26250884
[TBL] [Abstract][Full Text] [Related]
14. Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: data from the Surveillance Epidemiology and End Results database.
Groth SS; Virnig BA; Whitson BA; DeFor TE; Li ZZ; Tuttle TM; Maddaus MA
J Thorac Cardiovasc Surg; 2010 Mar; 139(3):612-20. PubMed ID: 19709685
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of signet ring cell histology in esophageal adenocarcinoma.
Yendamuri S; Huang M; Malhotra U; Warren GW; Bogner PN; Nwogu CE; Groman A; Demmy TL
Cancer; 2013 Sep; 119(17):3156-61. PubMed ID: 23719932
[TBL] [Abstract][Full Text] [Related]
16. Survival Impact of Total Resected Lymph Nodes in Esophageal Cancer Patients With and Without Neoadjuvant Chemoradiation.
Ho HJ; Chen HS; Hung WH; Hsu PK; Wu SC; Chen HC; Wang BY
Ann Surg Oncol; 2018 Dec; 25(13):3820-3832. PubMed ID: 30284131
[TBL] [Abstract][Full Text] [Related]
17. Dynamic nomograms combining N classification with ratio-based nodal classifications to predict long-term survival for patients with lung adenocarcinoma after surgery: a SEER population-based study.
Wang S; Yu Y; Xu W; Lv X; Zhang Y; Liu M
BMC Cancer; 2021 Aug; 21(1):653. PubMed ID: 34344326
[TBL] [Abstract][Full Text] [Related]
18. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
[TBL] [Abstract][Full Text] [Related]
19. Use of multimodality neoadjuvant therapy for esophageal cancer in the United States: assessment of 987 hospitals.
Merkow RP; Bilimoria KY; McCarter MD; Chow WB; Ko CY; Bentrem DJ
Ann Surg Oncol; 2012 Feb; 19(2):357-64. PubMed ID: 21769460
[TBL] [Abstract][Full Text] [Related]
20. Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.
Stiles BM; Mirza F; Coppolino A; Port JL; Lee PC; Paul S; Altorki NK
Ann Thorac Surg; 2011 Aug; 92(2):491-6; discussion 496-8. PubMed ID: 21704291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]